EPO practices and procedures in the field of pharmaceuticals and biotechnology


In view of the changing scenario of IP in India and the increasing number of international patent filings by Indian residents, IP practitioners in India, whether in private practice or industry, should be familiar with the latest developments at the EPO – the patent office for Europe - as far as filing, prosecution and examination procedures and practices in the field of pharma/biotech are concerned.

The seminar will provide a unique opportunity to gain a deep insight into the Pharma/Biotech practice of the EPO and to interact with leading EPO experts on the subject matter, Dr. A. Stamatopoulos, Principal Director Biotechnology / PAOC, Dr. Dieter Tzschoppe, Director Pharma, and Mr. Klaus-Peter Döpfer, Director Biotechnology.

The event is co-organised by the European Business Technology Centre (EBTC) and the European Patent Office (EPO).

Additional information